Peginterferon and Liver function test abnormal - a phase IV clinical study of FDA data

Summary:

Liver function test abnormal is reported as a side effect among people who take Peginterferon (peginterferon alfa-2a; ribavirin), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Ribavirin, and have Dyspnea.

The phase IV clinical study analyzes which people have Liver function test abnormal when taking Peginterferon. It is created by eHealthMe based on reports of 13,689 people who have side effects when taking Peginterferon from the FDA, and is updated regularly.

What is Peginterferon?

Peginterferon has active ingredients of peginterferon alfa-2a; ribavirin. It is often used in hepatitis c. eHealthMe is studying from 13,778 Peginterferon users. Check the latest studies of Peginterferon.

What is Liver function test abnormal?

Liver function test abnormal is found to be associated with 1,499 drugs and 1,963 conditions by eHealthMe. Check the latest studies of Liver function test abnormal.

On Jul, 24, 2026

13,689 people reported to have side effects when taking Peginterferon.
Among them, 23 people (0.17%) have Liver function test abnormal.

Could Peginterferon cause Liver function test abnormal?

Among these 23 people:

How long have people been on Peginterferon when they have Liver function test abnormal? *

What is the gender of people who have Liver function test abnormal when taking Peginterferon? *

female: 47.62 %
male: 52.38 %

What is the age of people who have Liver function test abnormal when taking Peginterferon? *

What are other drugs people take besides Peginterferon? *

What are other side effects people have besides Liver function test abnormal? *

Rashes (redness): 4 people, 17.39%
Thrombocytopenia (decrease of platelets in blood): 4 people, 17.39%
Hepatitis C Rna Increased: 3 people, 13.04%
Headache (pain in head): 2 people, 8.70%
Irritability: 2 people, 8.70%
Itching: 2 people, 8.70%
Fatigue (feeling of tiredness): 2 people, 8.70%
Nausea (feeling of having an urge to vomit): 2 people, 8.70%
Faeces Pale: 2 people, 8.70%
Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously): 2 people, 8.70%

What are the existing conditions these people have? *

Dyspnea (difficult or laboured breathing): 5 people, 21.74%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 2 people, 8.70%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 4.35%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 1 person, 4.35%
Pain: 1 person, 4.35%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 4.35%
Malignant Melanoma (skin cancer rises from melancytes): 1 person, 4.35%
Hiv Infection: 1 person, 4.35%
Erection Problems: 1 person, 4.35%
Depression: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Peginterferon and have Liver function test abnormal?

- Check whether Liver function test abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Peginterferon:

Peginterferon (13,778 reports)

Liver function test abnormal treatments and more:

Liver function test abnormal (39,450 reports)

How severe was Liver function test abnormal and when was it recovered:

Liver function test abnormal in Peginterferon

Expand to all the drugs that have ingredients of peginterferon alfa-2a; ribavirin:

Liver function test abnormal and drugs with ingredients of peginterferon alfa-2a; ribavirin

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Peginterferon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Liver function test abnormal:

Liver function test abnormal (1,499 drugs)

Browse all the conditions that are associated with Liver function test abnormal:

Liver function test abnormal (1,963 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on peginterferon alfa-2a; ribavirin (the active ingredients of Peginterferon) and Peginterferon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.